mesalamine has been researched along with Peritoneal Carcinomatosis in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aalders, MC | 1 |
| Sterenborg, HJ | 1 |
| Stewart, FA | 1 |
| van der Vange, N | 1 |
1 other study available for mesalamine and Peritoneal Carcinomatosis
| Article | Year |
|---|---|
Photodetection with 5-Aminolevulinic acid-induced protoporphyrin IX in the rat abdominal cavity: drug-dose-dependent fluorescence kinetics.
Topics: Animals; Dose-Response Relationship, Drug; Female; Fluorescent Dyes; Mesalamine; Neoplasm Transplant | 2000 |